Pill or puzzle? french study pits donepezil against brain exercises for Alzheimer's
NCT ID NCT04661280
First seen Feb 20, 2026 · Last updated Apr 27, 2026 · Updated 8 times
Summary
This study compares two approaches for people newly diagnosed with early Alzheimer's disease: taking the drug donepezil versus using non-drug methods like cognitive stimulation or remediation. Researchers want to see which approach better helps with memory and thinking symptoms after 6 months. About 240 participants aged 50 and older will be randomly assigned to one of the two groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE, EARLY ONSET are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Cognitive Neurology Center
RECRUITINGParis, 75010, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.